Exploration of Imaging Manifestations and CT Diagnostic Differentiation Effectiveness in Patients with Peripheral Lung Cancer and Pulmonary Inflammatory Masses
Objective:To explore the diagnostic value of CT in patients with peripheral lung cancer and pulmonary inflammatory masses.Methods:Using January 2023 to December 2023 as the data cutoff interval,46 patients with peripheral lung cancer and 46 patients with pulmonary inflammatory masses admitted to our hospital were selected,and the imaging manifestations and CT diagnostic differentiation value were analyzed.Results:The CT images of peripheral lung cancer showed significant differences in density,margin,pleural indentation sign,and vacuolar sign compared to inflammatory masses in the lungs (all P<0.05).According to the classification of lesion morphology,the accuracy of diagnosing pulmonary inflammatory masses was 71.74％ (33/46),sensitivity was 65.22％ (30/46),and specificity was 68.48％ (63/92).Based on the morphology of the lesion,combined with signs and medical history correction,the accuracy of the corrected diagnosis of pulmonary inflammatory masses was 82.61％ (38/46),sensitivity was 78.26％ (36/46),and specificity was 80.43％ (74/92).Conclusion:CT examination can provide a basis for distinguishing peripheral lung cancer from pulmonary inflammatory masses and guide the development of treatment plans.
peripheral lung cancerinflammatory mass in the lungsCTimaging manifestations
万方数据
维普
